Loading clinical trials...
Loading clinical trials...
A Multicenter, Single Arm, Post Marketing Surveillance Study to Monitor the Safety of Novartis Meningococcal ACWY Conjugate Vaccine (MenACWY-CRM) Administered According to the Prescribing Information to Healthy Subjects 2 Years of Age and Older in the Philippines
Conditions
Interventions
Novartis Meningococcal ACWY Conjugate Vaccine
Start Date
March 1, 2013
Primary Completion Date
April 1, 2016
Completion Date
April 1, 2016
Last Updated
December 1, 2016
NCT01725217
NCT03694405
NCT04358731
NCT01896596
NCT02811120
NCT03089086
Lead Sponsor
Novartis Vaccines
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions